T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCG
1251
DELISTED
Scana
SCG
| $12.7M | ﹤0.01% |
235,868
+3,000
| +1% | +$156K |
|
1252
Huron Consulting
HURN
$2.43B
| $12.7M | ﹤0.01% |
179,043
+18,200
| +11% | +$1.2M |
|
|
SZYM
1253
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $12.6M | ﹤0.01% |
1,068,920
-65,540
| -6% | -$699K |
|
|
HERO
1254
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $12.6M | ﹤0.01% |
3,129,279
+1,210
| +0% | +$5.4K |
|
1255
Mohawk Industries
MHK
$9.44B
| $12.5M | ﹤0.01% |
90,681
+1,000
| +1% | +$135K |
|
1256
Huntington Bancshares
HBAN
$36.2B
| $12.5M | ﹤0.01% |
1,312,715
| – | – |
|
1257
Jefferies Financial Group
JEF
$12.8B
| $12.5M | ﹤0.01% |
531,857
+2,681
| +0.5% | +$62.2K |
|
|
EXAS
1258
DELISTED
Exact Sciences
EXAS
| $12.4M | ﹤0.01% |
729,700
+701,500
| +2,488% | +$9.66M |
|
1259
ICICI Bank
IBN
$107B
| $12.4M | ﹤0.01% |
1,368,483
-283,261
| -17% | -$2.44M |
|
|
SWY
1260
DELISTED
SAFEWAY INC
SWY
| $12.4M | ﹤0.01% |
360,833
-42,251
| -10% | -$1.44M |
|
|
POM
1261
DELISTED
PEPCO HOLDINGS, INC.
POM
| $12.4M | ﹤0.01% |
450,700
-2,312,310
| -84% | -$58.9M |
|
1262
Globe Life
GL
$14.1B
| $12.4M | ﹤0.01% |
226,626
+5,100
| +2% | +$273K |
|
1263
WisdomTree India Earnings Fund ETF
EPI
$2.03B
| $12.4M | ﹤0.01% |
549,721
-71,600
| -12% | -$1.49M |
|
1264
NETSCOUT
NTCT
$2.87B
| $12.3M | ﹤0.01% |
278,100
+12,600
| +5% | +$489K |
|
|
WLL
1265
DELISTED
Whiting Petroleum Corporation
WLL
| $12.3M | ﹤0.01% |
511
+1
| +0.2% | +$22.2K |
|
|
KYTH
1266
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $12.3M | ﹤0.01% |
320,278
-47,041
| -13% | -$1.64M |
|
|
BYI
1267
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $12.2M | ﹤0.01% |
185,850
+20,100
| +12% | +$1.25M |
|
|
CATM
1268
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $12.1M | ﹤0.01% |
354,994
+23,800
| +7% | +$795K |
|
1269
Nabors Industries
NBR
$1.39B
| $12.1M | ﹤0.01% |
8,210
-190
| -2% | -$245K |
|
|
COHR
1270
DELISTED
Coherent Inc
COHR
| $12M | ﹤0.01% |
181,500
+23,900
| +15% | +$1.48M |
|
|
JPM.WS
1271
DELISTED
JPMorgan Chase
JPM.WS
| $11.9M | ﹤0.01% |
616,200
| – | – |
|
|
TTM
1272
DELISTED
Tata Motors Limited
TTM
| $11.9M | ﹤0.01% |
304,032
-12,210
| -4% | -$469K |
|
|
JMP
1273
DELISTED
JMP Group LLC
JMP
| $11.9M | ﹤0.01% |
1,567,512
+5,512
| +0.4% | +$36.9K |
|
|
GAS
1274
DELISTED
AGL Resources Inc
GAS
| $11.8M | ﹤0.01% |
214,116
+27,900
| +15% | +$1.47M |
|
|
BWLD
1275
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $11.8M | ﹤0.01% |
71,100
+12,000
| +20% | +$1.76M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.